U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
142951142951Study In Patients With Overactive Bladder Treated With Toviaz® After Failure Of Previous TherapyCompletedHas ResultsOveractive Bladder|Urinary IncontinenceDrug: fesoterodinehttps://ClinicalTrials.gov/show/NCT00691093
142952142952Treatment of Sleep Problems in Children With Autism Spectrum Disorder With MelatoninRecruitingNo Results AvailableSleep ProblemsDrug: Melatonin|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00691080
142953142953A Controlled Trial of Mifepristone in Gulf War Veterans With Chronic Multisymptom IllnessRecruitingNo Results AvailableChronic Multisymptom Illness in Gulf War VeteransDrug: mifepristone|Drug: placebohttps://ClinicalTrials.gov/show/NCT00691067
142954142954Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Did Not Respond to First-Line Therapy With GemcitabineCompletedHas ResultsPancreatic CancerDrug: Abraxanehttps://ClinicalTrials.gov/show/NCT00691054
142955142955A Network Intervention for Reducing Sexual Risk for HIV With African American Men Who Have Sex With Men (AA MSM)CompletedNo Results AvailableHIV InfectionsBehavioral: Unity in Diversityhttps://ClinicalTrials.gov/show/NCT00691041
142956142956Efficacy and Safety of Increased Dose of TA-650(Infliximab) in Patients With Rheumatoid ArthritisCompletedHas ResultsRheumatoid ArthritisDrug: TA-650 3 mg/kg|Drug: TA-650 6 mg/kg|Drug: TA-650 10 mg/kghttps://ClinicalTrials.gov/show/NCT00691028
142957142957Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell TransplantActive, not recruitingNo Results AvailableChronic Myeloproliferative Disorders|Leukemia|Lymphoma|Multiple Myeloma and Plasma Cell Neoplasm|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative NeoplasmsBiological: rituximab|Drug: busulfan|Drug: carmustine|Drug: cyclophosphamide|Drug: cytarabine|Drug: etoposide|Drug: fludarabine phosphate|Drug: melphalan|Radiation: total-body irradiationhttps://ClinicalTrials.gov/show/NCT00691015
142958142958Efficacy and Safety of Calcipotriol Plus Hydrocortisone Ointment in Psoriasis Vulgaris on the Face and Skin FoldsCompletedNo Results AvailablePsoriasis VulgarisDrug: Calcipotriol plus hydrocortisone (LEO 80190)https://ClinicalTrials.gov/show/NCT00691002
142959142959Retrospective Evaluation of Patient Failure to Follow-up at a Community Based Headache ClinicCompletedNo Results AvailableHeadachehttps://ClinicalTrials.gov/show/NCT00690989
142960142960Proyecto SOL: A Risk Reduction Intervention for Hispanic Men Who Have Sex With Men (MSM)CompletedNo Results AvailableHIV InfectionsBehavioral: Proyecto SOL|Behavioral: HCThttps://ClinicalTrials.gov/show/NCT00690976
142961142961Individual Boosting in Non-Small Cell Lung Cancer Using Hypofractionation, Intensity-modulated Radiation Therapy and Respiratory GatingActive, not recruitingNo Results AvailableCarcinoma, Non-Small-Cell LungProcedure: Radiotherapyhttps://ClinicalTrials.gov/show/NCT00690963
142962142962A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to AvodartEnrolling by invitationNo Results AvailableBenign Prostatic HyperplasiaDrug: Dutasteridehttps://ClinicalTrials.gov/show/NCT00690950
142963142963A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate HypercholesteremiaCompletedNo Results AvailableHypercholesterolemiaDrug: Enteric coated sevelamer|Drug: Enteric coated sevelamer|Drug: Colesevelam Cholestagel|Drug: Placebo|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00690937
142964142964Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung CancerRecruitingNo Results AvailableLung Cancer|Precancerous Condition|Tobacco Use DisorderDrug: calcitriol|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00690924
142965142965Study to Determine the Efficacy of Adalimumab in the Treatment of Cutaneous SarcoidosisWithdrawnNo Results AvailableSarcoidosisDrug: adalimumabhttps://ClinicalTrials.gov/show/NCT00690911
142966142966Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland MacroadenomaCompletedHas ResultsAcromegalyDrug: Lanreotide autogel 120 mghttps://ClinicalTrials.gov/show/NCT00690898
142967142967Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary FibrosisTerminatedNo Results AvailablePulmonary Disease, Chronic Obstructive|Pulmonary Fibrosis|CoughDrug: interferon-alpha lozenges|Drug: placebo lozengeshttps://ClinicalTrials.gov/show/NCT00690885
142968142968Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal CancerRecruitingNo Results AvailableHead and Neck CancerBiological: autologous Epstein-Barr virus-specific cytotoxic T lymphocytes|Drug: carboplatin|Drug: gemcitabine hydrochloride|Genetic: polymerase chain reaction|Other: fluorescence activated cell sorting|Other: immunoenzyme techniquehttps://ClinicalTrials.gov/show/NCT00690872
142969142969Predictors of Recurrence in Bipolar Disorder in SpainCompletedNo Results AvailableBipolar Disorderhttps://ClinicalTrials.gov/show/NCT00690859
142970142970Study to Determine the Safety and Efficacy of Adalimumab in the Treatment of Pyoderma GangrenosumWithdrawnNo Results AvailablePyoderma GangrenosumDrug: adalimumabhttps://ClinicalTrials.gov/show/NCT00690846
142971142971Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic DermatitisCompletedNo Results AvailableAtopic DermatitisDrug: topical desonide hydrogel 0.05%https://ClinicalTrials.gov/show/NCT00690833
142972142972Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)CompletedHas ResultsCystic Fibrosis|Pancreatic Exocrine InsufficiencyDrug: Pancrelipase Delayed Release|Drug: Placebo Comparatorhttps://ClinicalTrials.gov/show/NCT00690820
142973142973A Phase 2 Study of PH-10 for the Treatment of Atopic DermatitisCompletedNo Results AvailableAtopic DermatitisDrug: PH-10https://ClinicalTrials.gov/show/NCT00690807
142974142974Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular HypertensionCompletedHas ResultsOpen-angle Glaucoma|Ocular HypertensionDrug: Travoprost ophthalmic solution 0.004% with SofZia® preservative system (TRAVATAN Z®)|Drug: Latanoprost ophthalmic solution 0.005% (XALATAN®)https://ClinicalTrials.gov/show/NCT00690794
142975142975Protein Nutrition During Weight LossCompletedNo Results AvailableObesityDietary Supplement: Pulse casein feeding during energy restriction|Dietary Supplement: Spread casein feeding during energy restriction|Dietary Supplement: Pulse milk soluble protein feeding during energy restriction|Dietary Supplement: Spread milk soluble protein feeding during energy restrictionhttps://ClinicalTrials.gov/show/NCT00690781
142976142976Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)CompletedNo Results AvailableDiabetic Retinopathy|Retinal DetachmentDrug: Bevacizumab|Procedure: pars plana vitrectomyhttps://ClinicalTrials.gov/show/NCT00690768
142977142977Defective Atypical Protein Kinase C (PKC) Activation in Diabetes and Metabolic SyndromeCompletedNo Results AvailableDiabetes Mellitus, Type 2https://ClinicalTrials.gov/show/NCT00690755
142978142978[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT00690742
142979142979Cognitive-Behavioral Bibliotherapy for the Treatment of Obsessive Compulsive Disorder in Children and AdolescentsCompletedNo Results AvailableObsessive-Compulsive DisorderBehavioral: Cognitive Behavioral Bibliotherapy|Behavioral: Cognitive Behavioral Therapyhttps://ClinicalTrials.gov/show/NCT00690729
142980142980The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Mild Headache in People Who Experience MigrainesCompletedNo Results AvailableMigraineDrug: Nasal CO2|Drug: Inactive Placebohttps://ClinicalTrials.gov/show/NCT00690716

* Görseller ve İçerik tekif hakkına sahip olabilir